138 related articles for article (PubMed ID: 36590169)
1. Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.
Wu C; Hu B; Wang L; Wu X; Gu H; Dong H; Yan J; Qi Z; Zhang Q; Chen H; Yu B; Hu S; Qian Y; Dong S; Li Q; Wang X; Long J
iScience; 2023 Jan; 26(1):105723. PubMed ID: 36590169
[TBL] [Abstract][Full Text] [Related]
2. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
Zhang L; Yao J; Li W; Zhang C
Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
[TBL] [Abstract][Full Text] [Related]
3. Oleic acid from cancer-associated fibroblast promotes cancer cell stemness by stearoyl-CoA desaturase under glucose-deficient condition.
Hwang SH; Yang Y; Jung JH; Kim Y
Cancer Cell Int; 2022 Dec; 22(1):404. PubMed ID: 36514170
[TBL] [Abstract][Full Text] [Related]
4. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.
Hu C; Xia R; Zhang X; Li T; Ye Y; Li G; He R; Li Z; Lin Q; Zheng S; Chen R
Mol Cancer; 2022 Jan; 21(1):24. PubMed ID: 35045883
[TBL] [Abstract][Full Text] [Related]
5. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
7. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
8. Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.
Tsujii S; Serada S; Fujimoto M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Mol Cancer Ther; 2021 Dec; 20(12):2495-2505. PubMed ID: 34583978
[TBL] [Abstract][Full Text] [Related]
9. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
Ijichi H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
[TBL] [Abstract][Full Text] [Related]
10. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
11. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
[TBL] [Abstract][Full Text] [Related]
13. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
14. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
Shinkawa T; Ohuchida K; Nakamura M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460.
Zhu XX; Li JH; Ni X; Wu X; Hou X; Li YX; Li SJ; Zhao W; Yin XY
Cancer Sci; 2022 Nov; 113(11):3735-3750. PubMed ID: 36047966
[TBL] [Abstract][Full Text] [Related]
17. Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma.
Yan B; Liu L; Zhao L; Hinz U; Luo Y; An X; Gladkich J; de la Torre C; Huang Z; Schrapel D; Gross W; Fortunato F; Schaefer M; Gaida MM; Herr I
Matrix Biol; 2022 Dec; 114():84-107. PubMed ID: 36375776
[TBL] [Abstract][Full Text] [Related]
18. Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
Neumann CCM; von Hörschelmann E; Reutzel-Selke A; Seidel E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):461-472. PubMed ID: 30243879
[TBL] [Abstract][Full Text] [Related]
19. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in the Tumor Microenvironment Mediated by Exosomal MicroRNAs.
Chu X; Yang Y; Tian X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
